Search

Author/Creator Azuma, Yuichiro

2. Impact of pre‐existing interstitial lung abnormal shadow on lung injury development and severity in patients of non‐small cell lung cancer treated with osimertinib. (17th April 2022)

Authors:
Shibaki, Ryota; Ozawa, Yuichi; Noguchi, Susumu; Murakami, Yusuke; Takase, Eri; Azuma, Yuichiro; Maebeya, Masaru; Sugimoto, Takeya; Hayata, Atsushi; Hayakawa, Takahiro; Tamaki, Shinya; Nakanishi, Masanori; Teraoka, Shunsuke; Akamatsu, Hiroaki
Journal:
Cancer medicine
Issue:
Volume 11:Number 20(2022)
Page Start:
3743
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Prospective, multicentre, single-arm phase II trial of pembrolizumab combined with carboplatin and pemetrexed in elderly patients with advanced, non-squamous non-small cell lung cancer. Issue 7 (21st July 2020)

Authors:
Ozawa, Yuichi; Sugimoto, Takeya; Azuma, Yuichiro; Harutani, Yuhei; Yoshikawa, Takanori; Yamamoto, Nobuyuki; Kanai, Kuninobu
Journal:
BMJ open
Issue:
Volume 10:Issue 7(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Relationship between progression‐free survival and overall survival in patients with advanced non‐small cell lung cancer treated with anticancer agents after first‐line treatment failure. Issue 2 (9th May 2014)

Authors:
Suzuki, Hidekazu; Hirashima, Tomonori; Okamoto, Norio; Yamadori, Tadahiro; Tamiya, Motohiro; Morishita, Naoko; Shiroyama, Takayuki; Takeoka, Sawa; Osa, Akio; Azuma, Yuichiro; Kawase, Ichiro
Journal:
Asia-Pacific journal of clinical oncology
Issue:
Volume 11:Issue 2(2015:Jun.)
Page Start:
121
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗